Abbvie Inc risk profile
46 Elevated one input has moved against it
Measured 1 September 2026 from ABBV's filed statements. Recomputed nightly.
46 (Elevated), driven by Competitive position at 59, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 20 | Normal | Stable | One-year price volatility — 26.6% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 8 | Contained | Stable | Capital spending against operating cash — 0.06x |
| Leverage and coverage | 53 | Elevated | Easing | Net debt to EBITDA — 3.50x |
| Competitive position | 59 | Elevated | Worsening | Revenue-growth gap against peers — -20.7 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.